BLUEJET vs ORCHPHARMA: Stock Comparison

Blue Jet Healthcare Limited vs Orchid Pharma Limited

Live data: 22 July 2026, 2:56 PM IST • Source: NSE and company filings

Blue Jet Healthcare Limited is the larger company by market capitalisation. Blue Jet Healthcare Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Orchid Pharma Limited shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Blue Jet Healthcare Limited and Orchid Pharma Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, BLUEJET is more favourable on 8 of 11 scored metrics and ORCHPHARMA on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
BLUEJET is the larger company
₹10,169 Cr vs ₹5,072 Cr
P/E Ratio
BLUEJET has a lower P/E
41.21x vs 253.09x
P/B Ratio
ORCHPHARMA has a lower P/B
4.04x vs 7.51x
EPS
BLUEJET has higher earnings per share
₹14.27 vs ₹4.01
Dividend Yield
BLUEJET has a higher dividend yield
0.2% vs 0%
Revenue Growth (TTM YoY)
ORCHPHARMA has faster revenue growth
-1.5% vs -31.1%
EPS Growth (TTM YoY)
ORCHPHARMA has faster EPS growth
0% vs -41.5%
ROE
BLUEJET has a higher ROE
52.1% vs 2.12%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLUEJETORCHPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLUEJETORCHPHARMA
Live Price₹585.05₹999.75
Day Change-0.75%-2.27%
Volume5.49 L81,527
52-Week High₹1,022₹1,119.8
52-Week Low₹325₹480
Distance from 52W High-42.75%-10.72%

Valuation

MetricBLUEJETORCHPHARMA
Market Cap₹10,169 Cr₹5,072 Cr
P/E Ratio41.21x253.09x
P/B Ratio7.51x4.04x
EPS₹14.27₹4.01
Book Value₹78.41₹253.98
Dividend Yield0.2%0%

Growth

MetricBLUEJETORCHPHARMA
Revenue Growth (TTM YoY)-31.1%-1.5%
EPS Growth (TTM YoY)-41.5%0%
Qtr Sales Growth0.05%
Qtr Profit Growth4.26%

Profitability & Leverage

MetricBLUEJETORCHPHARMA
ROE52.1%2.12%
ROCE57.3%2.64%
Net Margin27.25%2.51%
Operating Margin41.3%5.07%
Debt to Equity0.16x0.28x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBLUEJETORCHPHARMA
Promoter Holding79.81%69.84%
FII Holding0.4% 0.48 pp0.87% 0.3 pp
DII Holding4.65% 0.14 pp20.25% 0.86 pp
Public Holding15.14% 0.34 pp9.05% 0.55 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Blue Jet Healthcare Limited and Orchid Pharma Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.